Vaccination delays risk third COVID death wave in Brazil, warns infectologist

Thousands dying daily (3,000-4,000 deaths/day); young survivors experiencing severe sequelae including cardiac complications, respiratory damage, and psychological trauma requiring extended recovery.
I could walk or speak, but not both at once
A COVID survivor describing the lingering physical toll months after leaving the hospital.

Health Ministry now projects September for completing priority group vaccination, up from May target, raising risk of new variants and mortality surge. Young adults increasingly affected with 1000% rise in hospitalizations ages 30-59 and severe long-term sequelae including cardiac complications and muscle weakness.

  • Health Ministry delayed priority group vaccination completion from May to September 2021
  • Hospitalizations of ages 30-59 surged over 1,000% between January and March
  • Deaths among ages 20-29 in São Paulo rose nearly 300% between February and March
  • Daily COVID deaths in Brazil hovered around 3,000-4,000 in April 2021

Infectious disease experts warn that delays in Brazil's vaccination schedule could trigger a third wave of COVID deaths, compounded by inability to enforce social isolation and emerging virus variants.

Brazil's health ministry pushed back its vaccination timeline in late April 2021, now projecting September instead of May to complete immunization of priority groups—the elderly, people with chronic conditions, and certain professions. The shift alarmed both the public, exhausted from waiting, and the scientific community, which saw in the delay a cascade of converging dangers.

Alexandre Cunha, a consultant with Brazil's infectious disease society, laid out the arithmetic plainly: a slow vaccination pace in a country unable to enforce social isolation creates the conditions for a third wave of deaths. The risks compound in three ways. First, the longer the virus circulates freely among unvaccinated people, the more likely new variants emerge—some potentially resistant to existing vaccines. Second, the historical pattern from Europe suggests a third surge of infection and mortality is not theoretical but probable, especially in regions that have already endured two waves. Third, no one yet knows how long vaccine-induced immunity lasts. Those vaccinated early could lose protection before the entire population is covered, leaving them vulnerable in the interval.

Health Minister Marcelo Queiroga blamed his predecessor's timeline as overly optimistic, citing supply chain obstacles the country faced. He said his team was working to compress the new schedule, but the damage to confidence was already done. The original May target had offered a concrete finish line. September felt distant and uncertain.

Meanwhile, the virus was reshaping its assault. Daily deaths had peaked above four thousand a few weeks prior and now hovered around three thousand—a plateau rather than a decline, with no clear trajectory downward. But the age profile of the sick was shifting. Hospitalizations among people aged thirty to fifty-nine had surged more than one thousand percent between early January and late March, according to epidemiological data from Fiocruz. Even younger adults were dying at alarming rates: deaths among those aged twenty to twenty-nine in São Paulo rose nearly three hundred percent between February and March.

Those who survived severe cases often carried the disease forward in their bodies. A physical trainer named Vilter Moraes, working with recovering patients in the interior of São Paulo, described the aftermath: muscle weakness, loss of muscle mass, breathing difficulties, irregular heartbeats. In some cases—even among previously healthy young athletes—blood clots formed in the heart. The survivors were often shocked. Their age and fitness had offered no protection.

Rosany Fonseca, a fifty-year-old psychologist and civil servant, contracted the virus from her husband in late December after he returned from travel asymptomatic. She spent ten days in the hospital in January, seven of them in intensive care. Despite her habit of walking five kilometers daily, her body failed rapidly. At her worst, she was taking high-dose medications every four hours and begged for something to help her sleep. She asked God to care for her children and accept whatever came next. The doctor increased her medication further. She was never intubated, but the margin was thin.

Months later, in early March, a new CT scan showed her lungs still thirty to fifty percent compromised, marked with white patches from the infection. She was on blood thinners, steroids, antibiotics, and stomach medication—a regimen lasting sixty days. Walking to the market and carrying groceries exhausted her. She could walk or speak, but not both at once. The psychological weight matched the physical toll. For more than a month after leaving the hospital, she wept daily, convinced that everything would end in death or catastrophe. When her son was five minutes late returning from a nearby store, she spiraled into panic. She developed post-traumatic stress disorder and began taking antidepressants to manage the anxiety that robbed her of sleep. She called her survival a rebirth—January twenty-second marked the day she came back to life—but the life she returned to was one of constant negotiation with her own fragility, one in which she had to relearn how to exist in a body that no longer obeyed her will.

A slow vaccination pace in a country unable to enforce social isolation can provoke a third major wave of deaths, with risks of new variants, immunity loss in early vaccinees, and another surge of infection and mortality.
— Alexandre Cunha, consultant with Brazil's infectious disease society
The disease destroys you physically and emotionally. After I left the hospital, I had crying episodes every day, convinced everything would end in death or tragedy.
— Rosany Fonseca, COVID survivor
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does the vaccination delay matter so much if people are already getting shots?

Model

Because speed is the whole point. Every day unvaccinated people remain vulnerable, the virus spreads and mutates. If you vaccinate slowly while transmission is still high, you're essentially giving the virus time to evolve around your vaccine.

Inventor

But couldn't Brazil just wait until September? People have waited this long.

Model

The problem is what happens between now and then. A third wave could kill thousands more. And people vaccinated first might lose immunity before everyone else gets their shot, leaving them exposed again.

Inventor

That sounds theoretical. What's actually happening on the ground?

Model

Young people are getting severely ill in ways they didn't before. Hospitalizations in their thirties and forties jumped over a thousand percent in a few months. Some survive but can't walk up stairs or carry groceries without collapsing.

Inventor

Is that permanent?

Model

No one knows yet. Some people are still recovering months later. One woman was told six months of recovery, and she's still on medications, still can't do normal things. The psychological damage is real too—PTSD, daily panic attacks.

Inventor

So the delay doesn't just risk more deaths. It risks more people living with broken bodies.

Model

Exactly. And the longer vaccination takes, the more variants have time to emerge. You could vaccinate everyone and still face a virus the vaccine doesn't recognize.

Inventor

What would faster vaccination have prevented?

Model

Thousands of deaths, for one. And countless people like Rosany Fonseca—people who would have been protected before the virus found them.

Quer a matéria completa? Leia o original em Brasil 247 ↗
Fale Conosco FAQ